Related references
Note: Only part of the references are listed.Long-term cardiovascular outcomes of COVID-19
Yan Xie et al.
NATURE MEDICINE (2022)
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19
Csilla Varnai et al.
JAMA NETWORK OPEN (2022)
Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19
Mariana Corrochano et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)
Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19
Jose Miguel Rivera-Caravaca et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Direct oral anticoagulant use and risk of severe COVID-19
B. Flam et al.
JOURNAL OF INTERNAL MEDICINE (2021)
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
Sean X. Gu et al.
NATURE REVIEWS CARDIOLOGY (2021)
Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors
Tingxuan Yin et al.
BMC INFECTIOUS DISEASES (2021)
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study
Richard Chocron et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P. Grivas et al.
ANNALS OF ONCOLOGY (2021)
Metoprolol in Critically Ill Patients With COVID-19
Agustin Clemente-Moragon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease
Elena Tessitore et al.
OPEN HEART (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang et al.
LANCET ONCOLOGY (2020)
The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer Comment
Samuel M. Rubinstein et al.
CANCER CELL (2020)
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Lennard Y. W. Lee et al.
LANCET (2020)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Prevalence of co-morbidities and their association with mortality in patients withCOVID-19: A systematic review and meta-analysis
Awadhesh K. Singh et al.
DIABETES OBESITY & METABOLISM (2020)
COVID-19 mortality in patients on anticoagulants and antiplatelet agents
Helena Sivaloganathan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
CANCER CELL (2020)
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
Kamal S. Saini et al.
EUROPEAN JOURNAL OF CANCER (2020)